Kolexia
Neuzillet Cindy Gastro-entérologie
Neuzillet Cindy
Gastro-entérologie
Institut Curie
Saint-Cloud, France
344 Activités
1.6 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du pancréas Adénocarcinome Carcinomes Cholangiocarcinome Tumeurs des voies biliaires Carcinome du canal pancréatique Tumeurs colorectales Carcinome hépatocellulaire Tumeurs des canaux biliaires

Collaborateurs

Voir plus
Hammel Pascal
Hammel Pascal
Hôpital Paul Brousse, Villejuif, France
Raymond Eric
Raymond Eric
Gh Paris Site Saint Joseph, Paris, France
Turpin Anthony
Turpin Anthony
Hôpital Huriez, Lille, France
Lievre Astrid
Lievre Astrid
Hôpital Pontchaillou, Rennes, France

Industries

Voir plus
Servier
46 collaboration(s)
Dernière en 2023
AstraZeneca
26 collaboration(s)
Dernière en 2023
Incyte
16 collaboration(s)
Dernière en 2023
Merck-Serono
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC biology   20 février 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring gene fusions.
Future oncology (London, England)   13 février 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
PACsign: Pilot Study of Personalized First-line Chemotherapy Choice for Patients With Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
Essai Clinique (Institut Curie)   29 janvier 2024
ProActIF-01 Trial: Randomized Study of Evaluation of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Lung or Digestive Cancers
Essai Clinique (Institut Curie)   26 janvier 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 janvier 2024
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy): A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)
Essai Clinique (Merus N.V.)   12 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Journal of the National Comprehensive Cancer Network : JNCCN   16 décembre 2023